VC
Vivo Capital Portfolio holdings
AUM
$977M
This Quarter Return
0%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$879M
AUM Growth
+$879M
(-18%)
Cap. Flow
-$188M
Cap. Flow
% of AUM
-21.43%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
51
New
5
Increased
–
Reduced
–
Closed
46
Top Buys
No buys this quarter
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$237M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$84.4M |
| 3 |
Arrowhead Research
ARWR
|
$73.3M |
| 4 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$56.2M |
| 5 |
Codexis
CDXS
|
$48.2M |
Sector Composition
| 1 | Healthcare | 0% |
| 2 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Aclaris Therapeutics
ACRS
$209M
| – | – | -1,647,214 | Closed | -$3.61M |
|
|
AKTX
2
Akari Therapeutics
AKTX
$24.8M
| – | – | -345,850 | Closed | -$699K |
|
3
Apellis Pharmaceuticals
APLS
$3.48B
| – | – | -383,538 | Closed | -$9.72M |
|
|
4
Arrowhead Research
ARWR
$3.05B
| – | – | -2,765,153 | Closed | -$73.3M |
|
|
5
Ascendis Pharma
ASND
$11.8B
| – | – | -2,060,135 | Closed | -$237M |
|
6
Aurinia Pharmaceuticals
AUPH
$1.58B
| – | – | -1,913,623 | Closed | -$12.6M |
|
|
7
Codexis
CDXS
$246M
| – | – | -2,614,458 | Closed | -$48.2M |
|
|
8
Crinetics Pharmaceuticals
CRNX
$2.92B
| – | – | -3,375,169 | Closed | -$84.4M |
|
|
DBVT
9
DBV Technologies
DBVT
$264M
| – | – | -269,995 | Closed | -$2.22M |
|
10
Precision BioSciences
DTIL
$57.8M
| – | – | -280,511 | Closed | -$3.72M |
|
11
Galmed Pharmaceuticals
GLMD
$6.96M
| – | – | -971,337 | Closed | -$7.14M |
|
12
Insmed
INSM
$28.8B
| – | – | -1,748,174 | Closed | -$44.8M |
|
13
Iovance Biotherapeutics
IOVA
$807M
| – | – | -1,600,000 | Closed | -$39.2M |
|
14
KALA BIO
KALA
$78.8M
| – | – | -1,043,020 | Closed | -$6.65M |
|
15
KalVista Pharmaceuticals
KALV
$678M
| – | – | -1,359,149 | Closed | -$30.1M |
|
16
Kiniksa Pharmaceuticals
KNSA
$2.48B
| – | – | -843,478 | Closed | -$11.4M |
|
17
MEI Pharma
MEIP
$160M
| – | – | -5,681,397 | Closed | -$14.2M |
|
18
Matinas BioPharma
MTNB
$10.1M
| – | – | -6,818,181 | Closed | -$5.84M |
|
19
Rocket Pharmaceuticals
RCKT
$354M
| – | – | -786,712 | Closed | -$11.8M |
|
20
Cartesian Therapeutics
RNAC
$261M
| – | – | -546,054 | Closed | -$977K |
|
21
Soleno Therapeutics
SLNO
$3.6B
| – | – | -4,268,959 | Closed | -$12M |
|
22
VYNE Therapeutics
VYNE
$8.16M
| – | – | -4,011,236 | Closed | -$24M |
|
23
Xenon Pharmaceuticals
XENE
$2.98B
| – | – | -1,405,476 | Closed | -$13.9M |
|
24
Zymeworks
ZYME
$1.12B
| – | – | -1,453,467 | Closed | -$32M |
|
25
Q32 Bio
QTTB
$20.9M
| – | – | -1,159,742 | Closed | -$22.7M |
|